Originally, NOX1 was described as an NADPH oxidase that stimulated mitogenesis (Arnold et al., 2001); however, subsequent studies collectively suggested NOX1 to be a driver of hypertension (Matsuno et al., 2005; Dikalova et al., 2005; Gavazzi et al., 2006). This evidence concerns the gene FMO5 and hypertensive disorder.